Table 3.

Reasons for exclusion from this analysis of patients who achieved partial or complete remission at week 26

CsA Group (n)MMF/DEX Group (n)
Missing eGFR, UP/C, or medication information at week 52 or week 78102
Not on all prescribed study medications at week 5224
Nonstudy immunosuppressive drug (e.g., CsA, tacrolimus) given between week 52 and week 7850
  • CsA, cyclosporin A; MMF/DEX, mycophenolate mofetil/dexamethasone; eGFR, estimated GFR; UP/C, urinary protein/creatinine ratio.